SPAC Deals in Singapore and Hong Kong Appear to be Fizzling Out

It’s been a slow and cautious start for SPACs that launched in Hong Kong and Singapore in recent months — in stark contrast to last year’s SPAC boom in the U.S. which has also fizzled out, CNBC reports.

Only one SPAC was launched in Hong Kong in the first quarter and it raised $128 million, while three were launched in Singapore, raising a total of $334 million, according to data analytics firm Refinitiv. Read more.

Total
0
Shares
Related Posts
Thimble Point Acquisition
Read More

Pear Therapeutics Seeking a Financial Lifeline

Pear Therapeutics went public in December 2021 in a $1.6 billion deal with Thimble Point Acquisition. It has seen its share price go from a high of trading at $5.22 per share to penny stock value, hovering around 49 cents a share.
mu-plugins updates